For the Inventor, By the Inventor

Enter assignee name

Zurich-Schlieren, Switzerland

Cytos Biotechnology Ag

USPTO Granted Patents = 31

CIPO Patents = 3

EPO Patents = 10

Forward Citations = 436

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

Martin F Bachmann (24 out of 27 patents)

Patrik Maurer (10 out of 11 patents)

Alain Tissot (9 out of 10 patents)

4. Wolfgang Andreas Renner (8 out of 13 patents)

5. Paul Pumpens (4 out of 8 patents)

6. Indulis Cielens (4 out of 5 patents)

7. Regina Renhofa (4 out of 5 patents)

8. Philippe Paul Saudan (3 out of 4 patents)

9. Katrin Schwarz (3 out of 4 patents)

10. Edwin Meijerink (3 out of 5 patents)

11. Karl Proba (3 out of 7 patents)

12. Gunther Spohn (3 out of 3 patents)

13. Peter Sebbel (3 out of 3 patents)

14. Franziska Lechner (3 out of 3 patents)

15. Frank Hennecke (3 out of 3 patents)

31 patents: Sort by Forward Citations

1. 8691209 - Packaging of immunostimulatory substances into virus-like particles: method of preparation and use (2014-04-08),

2. 8586728 - Oligonucleotides containing high concentrations of guanine monomers (2013-11-19),

3. 8574564 - Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity (2013-11-05),

4. 8541559 - Process for producing aggregated oligonucleotides (2013-09-24),

5. 8449874 - Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseases (2013-05-28),

6. 8344111 - Human monoclonal nicotine specific antibodies (2013-01-01),

7. 8187607 - Hapten-carrier conjugates and uses thereof (2012-05-29),

8. 7959928 - VLP-antigen conjugates and their uses as vaccines (2011-06-14),

9. 7959924 - Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof (2011-06-14),

10. 7888098 - Scalable process for protein purification (2011-02-15),

11. 7785873 - Antigen arrays for treatment of bone disease (2010-08-31),

12. 7767212 - CAT allergen conjugates and uses thereof (2010-08-03),

13. 7666408 - Angiotensin peptide-carrier conjugates and uses thereof (2010-02-23),

14. 7572451 - Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof (2009-08-11),

15. 7517520 - Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use (2009-04-14),

Cytos Biotechnology AG is a biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of cancer and infectious diseases. With a strong expertise in synthetic vaccines, Cytos aims to revolutionize the field of immunotherapy by developing personalized treatments that harness the power of the immune system. Through its proprietary platform, Cytos has successfully created novel therapeutic approaches that have shown promising results in clinical trials. The company is dedicated to improving patient outcomes and aims to bring forth breakthrough therapies that can address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

31 Patents

#1 in Zurich-Schlieren

#417 in Switzerland

#20,637 in the World

Zurich-Schlieren, Switzerland

Cytos Biotechnology Ag

Forward Citations = 436

47 inventors:

Martin F Bachmann (24 out of 27 patents)

Patrik Maurer (10 out of 11 patents)

Alain Tissot (9 out of 10 patents)

4. Wolfgang Andreas Renner (8 out of 13 patents)

5. Paul Pumpens (4 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…